CP and metabolic dysfunction-associated steatotic liver disease: Moreover, the alterations in iron and lipids metabolisms observed in the liver and adipose tissue in the absence of Cp may also have implications in other metabolic pathologies like nonalcoholic fatty liver disease characterized by aberrant iron/lipids homeostasis and altered adipokines expression [41,42,43], in which Cp levels have been found to be reduced [44,45,46,47,48].